Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

While Washington Stews, You Can Cash In on the Biggest "Tax-Inversion" Deal in History

Back in June 2012, we recommended that you pick up shares of Big Pharma player Abbott Laboratories Inc. (NYSE: ABT). The reason: Abbott was planning to split in two at the end of the year, meaning folks who took our advice would end up with stakes in two companies for the price of one.

There was more than bargain-basement thinking at work here.

You see, these corporate breakups – known as spin-offs – have a habit of turning into market-beating profit plays. And the newly minted spin-off firms often end up as takeover fodder – also at big profits.

Abbott followed part of that blueprint.

  • Featured Story

    These Tech Breakthroughs Are Too Big to Ignore

    Of all the concerts I went to in my younger days, a Ramones performance I attended at the historic Fillmore auditorium more than 20 years ago is the one I remember the best.

    I remember it so well because I couldn't hear for three days.

    As a musician, the experience gave me an indescribable scare; though I attended more concerts, I'd learned my lesson and promised to never let that happen again.

    But others haven't been so lucky.

    Two decades later, volume-related hearing loss is one of the few bridges spanning the so-called "digital divide" - the gulf that separates Baby Boomers like me from the smartphone-savvy Millennials that are half our age. For older adults, too much loud music at rock concerts is a common cause. For our younger "Generation Y" counterparts, it's the "ear-bud" headphones that blast music from iPods or other mobile devices.

    But the millions of Americans who currently suffer from hearing loss may finally have hope ... thanks to new "ear drops."

    To continue reading, please click here...


    Read More...
  • public tech companies